CLOVIQUE Drug Patent Profile
✉ Email this page to a colleague
When do Clovique patents expire, and what generic alternatives are available?
Clovique is a drug marketed by Chartwell Rx and is included in one NDA.
The generic ingredient in CLOVIQUE is trientine hydrochloride. There are ten drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Clovique
A generic version of CLOVIQUE was approved as trientine hydrochloride by WATSON LABS TEVA on February 7th, 2018.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLOVIQUE?
- What are the global sales for CLOVIQUE?
- What is Average Wholesale Price for CLOVIQUE?
Summary for CLOVIQUE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | CLOVIQUE at DailyMed |
US Patents and Regulatory Information for CLOVIQUE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | CLOVIQUE | trientine hydrochloride | CAPSULE;ORAL | 209731-001 | Oct 21, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
